A preliminary report of the use of botulinum toxin type A in infants with clubfoot: Four case studies

Journal of Pediatric Orthopaedics

Volumn 20, Issue 4, 2000, Pages 533-538

  Delgado, Mauricio R ^a,b,c   Wilson, Holly ^a,c   Johnston, Charles ^a,c,d   Richards, Steve ^a,c,d   Karol, Lori ^a,c,d  

^a TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^b Department of Neurology ^*  (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Botulinum toxin type A; Clubfoot; Pediatric

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CASE REPORT; CLUBFOOT; DEMYELINATING NEUROPATHY; DRUG EFFECT; GASTROCNEMIUS MUSCLE; HUMAN; INFANT; JOINT MOBILITY; MALE; PRIORITY JOURNAL; SURGICAL APPROACH; TIBIALIS POSTERIOR MUSCLE;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; CLUBFOOT; HUMANS; INFANT, NEWBORN; INJECTIONS, INTRAMUSCULAR; MALE; TREATMENT OUTCOME;

EID: 0033927498     PISSN: 02716798     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004694-200007000-00021     Document Type: Article

References (32)

1. Albanese A, Bentivogio AR, Cassetta E, Viggiano A, Maria G, Gui D. The use of botulinum toxin on smooth muscles. Eur J Neurol 1995;2:29-33.
2. Autti-Rämö I, Larsen A, Peltonen J, et al. The use of botulinum toxin treatment in children with movement disorders. Eur J Neurol 1997;4(suppl 2):S23-6.
3. Barnes MP. Experience of botulinum toxin in the management of spasticity. Eur J Neurol 1997;4(suppl 2):S33-6.
4. Bensahel H, Catterall A, Chir M, Dimeglio A. Practical applications in idiopathic clubfoot: a retrospective multicentric study in EPOS. J Pediatr Orthop 1990;10:186-8.
5. Blakeslee TJ, DeValentine SJ. Management of the resistant idiopathic clubfoot: the Kaiser experience from 1980-1990. J Foot Ankle Surg 1995;34:167-76.
6. Borodic GE, Ferrante RJ, Pearce LB, Alderson K. Pharmacology and histology of the therapeutic application of botulinum toxin. In: Jankovic J, Hallett M, eds. Therapy with botulinum toxin. New York: Marcel Dekker, 1994:120-1.
7. Brin MF, Fahn S, Moskowitz C, et al. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov Disord 1987;2:237-54.
8. Childers MD, Wilson DJ, Galate JF, Smith BK. Treatment of painful muscle syndromes with botulinum toxin: a review. J Back Musculoskel Rehabil 1998;10:89-96.
9. Chutorian AM, Root L. Management of spasticity in children with botulinum-A toxin. Intl Pediatr 1994;9(suppl 1):35-43.
10. Cohen-Sobel E, Caselli M, Giorgini R, Giorgini T, Stummer S. Long-term follow-up of clubfoot surgery: analysis of 44 patients. J Foot Ankle Surg 1993;32:411-23.
11. Corry IS, Cosgrove AP, Duffy CM, McNeill S, Taylor TC, Graham HK. Botulinum toxin A compared with stretching casts in the treatment of spastic equinus: a randomized prospective trial. J Pediatr Orthop 1998;18:304-11.
12. Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev Med Child Neurol 1994;36:386-96.
13. Delgado M. The use of botulinum toxin type A in children with cerebral palsy: a retrospective study. Eur J Neurol 1999;6(suppl 4):S11-8.
14. Diméglio A, et al. Classification of clubfoot. J Pediatr Orthop Pt B 1995;4:129-36.
15. Diméglio A, Bonnet F, Mazeau P, De Rosa V. Orthopaedic treatment and passive motion machine: consequences for the surgical treatment of clubfoot. J Pediatr Orthop 1996;5:173-80.
16. Drvaric DM, Kuivila TE, Roberts JM. Congenital clubfoot etiology, pathoanatomy, pathogenesis, and the changing spectrum of early management. Orthop Clin North Am 1989;20:641-7.
17. Dutton JJ. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short-and long-term, local and systemic effects. Surv Ophthalmol 1996;41:51-65.
18. Gooch JL, Sandell TV. Botulinum toxin for spasticity and athetosis in children with cerebral palsy. Arch Phys Med Rehabil 1996;5: 508-11.
19. Gormley ME Jr, Herring GM, Gaebler-Spira DJ. The use of botulinum toxin in children: a retrospective study of adverse reactions and treatment of idiopathic toe-walking. Eur J Neurol 1997:4(suppl 2):S27-30.
20. Reference deleted at proofs.
21. Hesse S, Mauritz K-H. Management of spasticity. Curr Opin Neurol 1997;10:498-501.
22. Jankovic J, Hallett M. Therapy with botulinum toxin. New York: Marcel Dekker, 1994.
23. Jankovic J, Schwartz K. Longitudinal experience with botulinum toxin injections for treatment of blepharospasm and cervical dystonia. Neurology 1993;43:834-5.
24. Koman LA, Mooney JF, Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop 1993;13:489-95.
25. Koman LA, Mooney JF III, Smith BP, Goodman A, Mulvaney T. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double blind trial. J Pediatr Orthop 1994;14:299-303.
26. O'Brien CF. Overview of clinical trials and published reports of botulinum toxin for spasticity. Eur J Neurol 1997;4(suppl 2): S11-3.
27. Osako M, Keltner JL. Botulinum A toxin (Oculinum) in ophthalmology. Surv Ophthalmol 1991;36:28-46.
28. Ponseti IV. Treatment of congenital club foot. J Bone Joint Surg Am 1992;74:448-54.
29. Richards BS, Wilson H, Johnston CE. Non-operative clubfoot treatment comparing the French technique to serial casting-early results. Presented at Pediatric and Orthopaedic Society of North America (POSNA). Lake Buena Vista, FL, May 15-19, 1999.
30. Sutherland DH, Kaufman KR, Wyatt MP, Chambers HG. Injection of botulinum A toxin into the gastrocnemius muscle of patients with cerebral palsy: a 3-dimensional motion analysis study. Gait Posture 1996;4:269-79.
31. Wong V. Use of botulinum toxin injection in 17 children with spastic cerebral palsy. Pediatr Neurol 1998;18:124-31.
32. Zelnik N, Giladi N, Goikhman I, Keren G, Moris R, Honigman S. The role of botulinum toxin in the treatment of lower limb spasticity in children with cerebral palsy: a pilot study, Isr J Med Sci 1997;33:129-33.